211.1 Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants
Dr. Maral Baghai Arassi, Germany
211.2 The Induction Conundrum: To Study the Impact of Induction Immunosuppression on the Incidence of Rejections and Infections, Graft and Patient Survival in Pediatric Kidney Transplant Recipients Retrospectively
Dr. Nayan Ashok Chaudhari, India
211.3 Effects of calcineurin inhibitors on renal function in paediatric liver transplant recipients at a tertiary academic hospital
Dr. Karabo Lesley K L Leotlela, South Africa
211.4 A five-year retrospective review of using a steroid minimisation national protocol at a single centre: Is mycophenolate mofetil less tolerated in the younger transplant recipient?
Dr. Jennifer R Martin, United Kingdom
211.5 Correlation between Human Leukocyte Antigen (HLA) Eplet Mismatch and Denovo Donor Specific Antibodies (dnDSA) development, in Paediatric Kidney Transplant Recipients (KTR): A Retrospective Cohort from a single Indian Centre
Dr. Kinnari Vala, India
211.6 Immunosuppressant withdrawal and characteristics of regulatory T cells in allograft histology among pediatric liver transplantation recipients
Prof. Kai Wang, People's Republic of China
211.7 Alternative, Low-Cost Monitoring of CD3 cell depletion following Anti-Thymocyte Globulin Induction in Pediatric Renal Transplant Recipients
Abanti Chaudhuri, United States
211.8 Pubertal stage specific changes in T-cell subpopulations in healthy individuals and pediatric kidney transplant recipients